STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders

STAAR Surgical Company (NASDAQ: STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, announced that based on ...
MedTech Dive

STAAR shareholders reject Alcon’s revised buyout offer

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...
Healio

Study: Vertical fixation more predictable for ICL implantation

Using vertical fixation for implantable collamer lens placement may improve clinical outcomes, according to a study published ...
Business Wire

STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ...
Seeking Alpha

Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL

Oct. 10, 2023 10:51 AM ETSTAAR Surgical Company (STAA) STAAR Surgical is equally enthusiastic about this collaboration. Tom Frinzi, CEO of STAAR Surgical, states, "We are happy to have Jimmy O. Yang ...
Nasdaq

STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024

“EVO ICL is the next logical step in refractive innovation. While adoption of any new technology takes time, EVO ICL’s adoption rate has been steadily rising since launch – achieving market leadership ...
Nasdaq

STAAR Surgical, SharpeVision Partner To Offer EVO ICL Lenses

(RTTNews) - STAAR Surgical Company (STAA) Tuesday announced partnership with ophthalmology group, SharpeVision to provide EVO ICL lenses to all qualified patients in SharpeVision clinics. STAAR ...
Business Wire

STAAR Surgical Teams Up With Tennessee Titans Quarterback Will Levis On Life Changing Vision Correction Procedure, EVO ICL

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced its partnership with Will ...
KELOLAND News

Vance Thompson Vision explains Implantable Collamer Lenses

Clear, sharp vision is a game-changer, and for those seeking an alternative to LASIK, Implantable Collamer Lens or ICL surgery offers an innovative solution. Unlike laser-based procedures, ICL ...
The Indianapolis Star

Collamer Sets EVO ICL Apart: Carrot LASIK & Eye Center Highlights the Lens Material That’s Changing Vision Correction

Carrot LASIK & Eye Center is shedding light on one of the most important but often overlooked aspects of refractive surgery—the material used in the implantable lens itself. In its latest article, EVO ...
The Desert Sun

Dr. Jason Brinton Selected as Principal Investigator for Landmark FDA Study Demonstrating Superior Safety and Efficacy of EVO ICL Technology

Prestigious three-year multicenter clinical trial confirms revolutionary implantable lens technology achieves exceptional visual outcomes with minimal complications Dr. Jason P. Brinton of Brinton ...

New $17 Million Bet on STAAR Surgical Comes as Sales Jump 7% and Margins Hit 82%

STAAR’s results show a story about timing, cash discipline, and what happens when reported growth finally lines up with ...